We have previously shown that on PC patients, positive SRSF-1 expression was associated with AR, Ki-67, IR-α, and microvascular density, indicating a potential role of SRSF-1 in driving tumor aggressiveness [15]. Here, SRSF1 is linked to pachyonychia congenita.